Welcome Customer !

Membership

Help

Shilian Boyan (Beijing) Technology Co., Ltd
Custom manufacturer

Main Products:

instrumentb2b>Products
Product Categories

Shilian Boyan (Beijing) Technology Co., Ltd

  • E-mail

  • Phone

  • Address

Contact Now

RCCS-4H Four Station Synchronous 3D Cell Culture System

NegotiableUpdate on 05/06
Model
Nature of the Manufacturer
Producers
Product Category
Place of Origin

Overview

The RCCS-4H four station synchronous 3D cell culture system is specially designed for scientific research and pharmaceutical development scenarios that require parallel experiments, batch modeling, and high-throughput screening. It adopts a rotating suspension culture and membrane ventilation design to provide cells with a 3D growth environment that is close to in vivo, low shear, and bubble free. Four sets of experiments can be conducted simultaneously at once, greatly improving experimental efficiency and data reliability. It is a popular choice among university laboratories, pharmaceutical companies CRO、 The ideal 3D cultivation platform for clinical research.

Product Details

1、 Core positioning

Four channel synchronous rotation, stable low shear, high oxygenation three-dimensional cultivation system, taking into account bothFlux, stability, and ease of useTo meet the needs of batch cell expansion, multiple control groups, drug screening, and large-scale preparation of organoids and tissue engineering, it is compatible with standard incubators, ready to use, and can operate stably for a long time.

2、 Core configuration

  • Four station synchronous rotating base, stable and adjustable speed

  • Specialized power supply and control module

  • Standard configuration includes 4 high-pressure sterilization culture containers (HARV/STLV optional)

  • Compatible with 1mL-500mL multi specification containers and disposable sterile containers

  • Silicone membrane for efficient ventilation, bubble free oxygen supply, and gentle cultivation throughout the process

3、 Core advantages

  1. Four station synchronous operation, doubling efficiency

    Complete four parallel/control experiments at once, with consistent conditions and good reproducibility, significantly shortening the experimental period and improving data persuasiveness.

  2. Low shear without damage, better cell state

    No stirring, no bubbles, low fluid shear, cells grow in a suspended state close to free fall, and primary cells, stem cells, tumor cells, and fragile tissues have higher survival rates and more stable functions.

  3. High fidelity 3D environment, closer to the body

    Stereoscopic growth, uniform oxygen supply, sufficient nutrient exchange, cells are not easily dedifferentiated, and can form three-dimensional clusters, organoids, and tissue models with structures and functions closer to those in the body.

  4. Compatible and flexible, adaptable to all scenarios

    Support microcarriers, biological scaffolds, cell spheres, and tissue block culture; Sampling can be done at any time without interrupting the cultivation process; Containers can be reused under high pressure, making long-term use more economical.

  5. Mature and stable, with high recognition

    Years of technological iteration and extensive laboratory validation, stable operation, simple maintenance, rich supporting literature, have been selected by many universities, hospitals, and pharmaceutical companies at home and abroad.

4、 Core purpose

  • High throughput drug screening, in vitro toxicology, efficacy evaluation, and dose gradient experiments

  • Batch tumor balls, organoids, and 3D tissue model construction

  • Research on synchronous expansion and differentiation of stem cells, primary cells, and immune cells

  • Multiple parallel controls, process optimization, and condition exploration

  • Tissue engineering, regenerative medicine, virus host interaction, long-term in vitro maintenance of tissues

  • Vaccine research and development, preparation of biological products, high-density cell culture

5、 Applicable scenarios

  • Universities/Research Institutes: Basic and Applied Research in Cell Biology, Oncology, Stem Cells, and Tissue Engineering

  • Pharmaceutical companies/CROs: New drug screening, safety evaluation, biopharmaceutical and vaccine development

  • Hospital/Clinical Laboratory: Organoid Drug Sensitivity, Individualized Treatment, Tissue Repair Research

  • Biological laboratory: batch cell culture, process scaling up, and parallel testing of diverse samples

  • Disease Control/Biosafety: Research on Three Dimensional Models and Infection Mechanisms of Highly Pathogenic Viruses